◢ TECHNICA.BIOBIOTECH ECOSYSTEM INTELLIGENCE
Polish Biotech Scene

Jutro Medical

AI-run primary care · Primary care

MarketVC-backed (private)WarsawAI-Driven Drug Discovery
Focus / modality
AI-run primary care
Lead asset
Digital clinic + AI
Type
AI / digital health
Indication
Primary care
Stage
Market
HQ
Warsaw
Capital tier
VC-backed (private)
Backing
VC

Overview

Tech-first primary-care provider automating routine GP workflows with AI; one of Poland's fastest-growing digital-health startups.

What they do

Jutro Medical, founded in 2020 and based in Warsaw, is a tech-first primary-care provider that pairs physical clinics with a digital-first care platform built on its own electronic health record (EHR). It automates routine GP workflows with AI, including medical AI agents intended to replace conventional telemedicine steps, and reports serving roughly 120,000 patients across Poland with high patient-satisfaction scores.

Lead program & status

The core product is its integrated primary-care stack (clinics plus proprietary EHR and AI agents). Funding has scaled quickly: in March 2025 Jutro raised €12M in Series A (led by KAYA VC and RIO ASI), and in December 2025 it extended the round with €24M led by Warsaw Equity Group, with Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC and Inovo participating, plus debt from mBank and Orbit Capital, taking total funding to about €36M. The capital funds clinic acquisitions (around 20 a year targeted) and expansion into other European markets, positioning it as an AI-enabled primary-care rollup.

Why it matters

Primary care is overloaded and administratively heavy. By owning the clinic, the EHR and the AI layer end-to-end, Jutro can automate routine work, control quality and consolidate fragmented practices, one of Poland's fastest-growing digital-health stories.

FAQ

What makes Jutro Medical different?
It owns the full primary-care stack: physical clinics, a proprietary EHR, and AI agents that automate routine GP and telemedicine workflows, rather than bolting software onto third-party systems.
How much has Jutro Medical raised?
About €36M in total, after a €12M Series A in March 2025 and a €24M Series A extension in December 2025 led by Warsaw Equity Group, including debt financing.
How many patients does Jutro Medical serve?
It reports serving roughly 120,000 patients across Poland and is pursuing clinic acquisitions (targeting around 20 per year) plus European expansion.

Technology

Jutro Medical works in AI-Driven Drug Discovery — Compressing years of trial-and-error chemistry into months of computation.

Read the AI-Driven Drug Discovery brief →

Related companies

Company website / source ↗ Open the interactive map →

◢ Boom-cycle briefing

Get ahead of the next biotech boom.

New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.

No spam · ~1–2 emails/month · unsubscribe anytime.
Curated biotech intelligence, compiled for orientation — not investment advice. Company stages, deals and figures move fast; verify against ClinicalTrials.gov, company filings and primary sources before acting.